Mary Chris Jaklevic is a freelance health care reporter and frequent contributor to HealthNewsReview.org. She tweets as @mcjaklevic.
Scientists should be lauded for investigating health claims used to a market a product. But when preliminary findings are reported to the public without appropriate context, that’s a problem.
And it’s one that we’ve seen twice in the past six months at Temple University.
In June we criticized an overreaching university news release: “Temple study: Extra-virgin olive oil preserves memory & protects brain against Alzheimer’s.” The study, based on research in just 22 mice that had been bred to develop Alzheimer’s-like plaques in the brain, didn’t show any connection between human brain health and olive oil. And it only belatedly mentioned the fact that the research was conducted in mice. But this did not deter several news outlets — including USA Today, Newsweek, the Atlanta Journal-Constitution, and Philadelphia Inquirer — from covering it anyway.
The study compared mice given a standard diet with mice given a standard diet plus a tablespoon of olive oil daily in terms of their performance on memory tests.
HealthNewsReview.org Deputy Managing Editor Joy Victory touched on some of the many problems with that study, and the resulting coverage, writing:
Stating the obvious, here, but genetically modified mice are a far, far cry from people. And just because you’re able to reduce amyloid buildup in those genetically modified mice, doesn’t mean you’ll be able to do the same thing in humans.
In fact, even drugs that apparently do a great job of getting rid of amyloid in thousands of actual humans don’t seem to have much effect on the symptoms of Alzheimer’s disease.
Six months later, you’d hope that whomever is responsible for this messaging might have rethought their approach. But no, they’re at it again, this time with a similarly shaky study using the same methodology to claim canola oil could be bad for the brain. Yesterday Temple issued this attention-grabbing news release: Canola oil linked to worsened memory & learning ability in Alzheimer’s.
Once again, the headline jumps way ahead of what the research actually shows.
Nevertheless, the clickbait machine is whirring again. We spotted these hastily reported stories:
Only the Inquirer warned readers about relying on a mouse study, stating in the second paragraph: “The results should be viewed with caution because what happens in mice often does not happen in people.” But that warning came only after baiting readers with the overreaching headline.
The Inquirer’s story also contains information that’s not in the news release and does serve to temper some of the hype. It reports that the senior investigator “considers the study a ‘red flag’ for canola oil users, though he would not tell people to stop eating it,” that he plans to experiment with different fats and doses “to see how much is needed to induce brain changes and whether changes are reversible,” and that he acknowledges not knowing why canola oil and olive oil might affect the brain differently.
Unfortunately, none of these news outlets sought comments from outside experts who could have added much-needed perspective. That’s one of several tips we offer in: “How to report on preliminary Alzheimer’s research results.”
It’s good when researchers look into the health effects of products, like canola oil, that are promoted with industry-funded research. But this new study doesn’t say anything meaningful for consumers; it’s simply one more example of the overblown diet claims that drive public skepticism of the field of nutrition science.
Comments (1)
We Welcome Comments. But please note: We will delete comments left by anyone who doesn’t leave an actual first and last name and an actual email address.
We will delete comments that include personal attacks, unfounded allegations, unverified facts, product pitches, or profanity. We will also end any thread of repetitive comments. Comments should primarily discuss the quality (or lack thereof) in journalism or other media messages about health and medicine. This is not intended to be a forum for definitive discussions about medicine or science. Nor is it a forum to share your personal story about a disease or treatment -- your comment must relate to media messages about health care. If your comment doesn't adhere to these policies, we won't post it. Questions? Please see more on our comments policy.
Kevin Folta
December 10, 2017 at 11:23 amWell done. I was really shocked by how irresponsibly this is being interpreted and disseminated. It looks like it starts a little with the authors, but a lot with the Temple University press release. What the report shows is that disease-model mice fattened up with oil have some differences in behavior and neural biochemistry markers. That’s it!
https://medium.com/@kevinfolta/science-illiteracy-strikes-again-canola-oil-is-not-causing-alzheimers-and-dementia-c5694fd536b
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like
Did you know that growth in the per capita consumption of mozzarella cheese in the…
Each week, the staff at HealthNewsReview.org collectively spends hours scanning news releases and news stories,…
What a story from USA Today: “Extra virgin olive oil staves off Alzheimer's, preserves memory,…